In Alzheimer's disease, overexpression of SRF and myocardin in small cerebral arteries was shown to contribute to the pathogenesis of the condition as they increase arterial contractility and reduced blood flow due to the activation of SRF‐dependent SM contractile genes [13, 82]. Here, MYOCD is linked to Alzheimer disease.